⟳ Репост от nhed
The FDA is poised to render a decision on Moderna's mRNA-based flu shot, which could be the first of its kind to market. The decision is expected to reverberate throughout the biotech industry. n.pr/4xcvuWu
The FDA is poised to render a decision on Moderna's mRNA-based flu shot, which could be the first of its kind to market. The decision is expected to reverberate throughout the biotech industry. n.pr/4xcvuWu
Публичный счётчик показывает 18, а источник передал 0. Остальные ответы могли быть удалены, скрыты или не выданы публично.
Обсуждение ещё не началось.